TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency August 14, 1992
TCL Archive Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients December 28, 2012